Literature DB >> 35137370

First Wave of COVID-19 Pandemic in Italy: Data and Evidence.

Daiana Bezzini1, Irene Schiavetti2, Tommaso Manacorda3,4, Giorgia Franzone5, Mario A Battaglia6,3.   

Abstract

INTRODUCTION: Unexpectedly, Italy was the first Western country to face COVID-19 outbreak, but promptly it was the first one to adopt stringent procedures to stem the spread of infection. The objective of this study was to describe the epidemiological situation and comorbidities in Italy, in addition to containment measures and health system and social protection strengthening ones applied in this country.
METHODS: Available population data were collected, managed, and analysed from the daily reports on COVID-19 published every day, from 1 February to 8 June 2020.
RESULTS: Lombardia, a northern region of Italy, is considered the epicentre for the wave of the infection with the first diagnosed case, but in a few weeks other regions were involved (with Piemonte, Emilia-Romagna, and Veneto covering more than 70% of the Italian total cases). In the European context, after 3 months of containing measures of the sanitary emergency, Italy is the fourth country for the number of total positive cases (with 235,278 total case as at 8 June 2020), after Russia, the United Kingdom, and Spain, whereas it is the second for the number of deaths (with 33,964 deaths as at 8 June 2020), only after the United Kingdom. Regarding incidence, the curve of daily new cases shows an increasing trend up to 22 March 2020 with 6557 new daily cases and then a decreasing trend up to 280 as at 8 June. This turnaround can be explained by the application of national lockdown starting from 9 March and by the following 14 days of incubation of infection. Profiles of subjects at major risk of poor prognosis and death for COVID-19 are elderly (mean age of 80 years) and with three or more comorbidities. These characteristics can partially explain the high lethality rate for coronavirus observed in Italy, which is the European country with the highest share of elderly. In addition, other possible explanations of this high lethality are differences in testing policies among countries that influence the number of asymptomatic or pauci-symptomatic patients diagnosed as coronavirus positive, together with differences in definition and in the way of recording deaths for coronavirus. In the absence of a vaccine, severe nonpharmaceutical interventions (NPIs), including national lockdown, quarantine, social distancing, and use of facial masks, have been applied with success to reduce the virus spread and the burden on the National Health System. In addition to these stringent containment measures to fight the pandemic, other policies have been adopted searching to ensure economic sustainability, social safety, and stability.
CONCLUSION: Italy was the first Western country with a wide spread of COVID-19, but it was the first one to introduce containment restrictions, tightening them week by week and subjecting the 60 million people living in the country to unprecedented limitations. Many measurements have been adopted by the government, such as lockdown during the early stages of infection and subsequent social distancing and wearing face masks in public areas. Italians were compliant with all the measures ordered by the government and their discipline reflected in the COVID numbers: the curve of daily new cases after a peak at the end of March now shows a consistent decreasing trend up. In this phase of current reduction of virus diffusion, it is crucial to accommodate the need to continue protecting citizens from the risk of infection with the undeferrable, although gradual, restart of the economic and social system. This new scenario requires an active collaboration among all the actors: statutory bodies, employers, civil society, and the third sector.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Comorbidities; Containment measures; Economic sustainability; Incidence; Lethality; Mortality; NPI; Novel coronavirus; Prevalence; Social protection

Mesh:

Year:  2021        PMID: 35137370     DOI: 10.1007/978-3-030-85113-2_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

1.  Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis.

Authors:  Alessandro Mantovani; Giorgia Beatrice; Andrea Dalbeni
Journal:  Liver Int       Date:  2020-04-24       Impact factor: 5.828

2.  Public health interventions and epidemic intensity during the 1918 influenza pandemic.

Authors:  Richard J Hatchett; Carter E Mecher; Marc Lipsitch
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-06       Impact factor: 11.205

3.  Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy.

Authors:  Riccardo M Inciardi; Marianna Adamo; Laura Lupi; Dario S Cani; Mattia Di Pasquale; Daniela Tomasoni; Leonardo Italia; Gregorio Zaccone; Chiara Tedino; Davide Fabbricatore; Antonio Curnis; Pompilio Faggiano; Elio Gorga; Carlo M Lombardi; Giuseppe Milesi; Enrico Vizzardi; Marco Volpini; Savina Nodari; Claudia Specchia; Roberto Maroldi; Michela Bezzi; Marco Metra
Journal:  Eur Heart J       Date:  2020-05-14       Impact factor: 29.983

4.  Coronavirus: Older Persons With Cancer in Italy in the COVID-19 Pandemic.

Authors:  Lucia Fratino; Giuseppe Procopio; Massimo Di Maio; Saverio Cinieri; Silvana Leo; Giordano Beretta
Journal:  Front Oncol       Date:  2020-04-30       Impact factor: 6.244

5.  Spread and dynamics of the COVID-19 epidemic in Italy: Effects of emergency containment measures.

Authors:  Marino Gatto; Enrico Bertuzzo; Lorenzo Mari; Stefano Miccoli; Luca Carraro; Renato Casagrandi; Andrea Rinaldo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-23       Impact factor: 11.205

6.  Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus.

Authors:  Calistus N Ngonghala; Enahoro Iboi; Steffen Eikenberry; Matthew Scotch; Chandini Raina MacIntyre; Matthew H Bonds; Abba B Gumel
Journal:  Math Biosci       Date:  2020-05-01       Impact factor: 2.144

7.  Obesity prolongs the hospital stay in patients affected by COVID-19, and may impact on SARS-COV-2 shedding.

Authors:  Diego Moriconi; Stefano Masi; Eleni Rebelos; Agostino Virdis; Maria Laura Manca; Salvatore De Marco; Stefano Taddei; Monica Nannipieri
Journal:  Obes Res Clin Pract       Date:  2020-06-04       Impact factor: 2.288

8.  Clinical Characteristics and Outcomes of COVID-19 Patients With a History of Stroke in Wuhan, China.

Authors:  Chuan Qin; Luoqi Zhou; Ziwei Hu; Sheng Yang; Shuoqi Zhang; Man Chen; Haihan Yu; Dai-Shi Tian; Wei Wang
Journal:  Stroke       Date:  2020-05-29       Impact factor: 7.914

9.  Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy.

Authors:  Fabio Ciceri; Antonella Castagna; Patrizia Rovere-Querini; Francesco De Cobelli; Annalisa Ruggeri; Laura Galli; Caterina Conte; Rebecca De Lorenzo; Andrea Poli; Alberto Ambrosio; Carlo Signorelli; Eleonora Bossi; Maria Fazio; Cristina Tresoldi; Sergio Colombo; Giacomo Monti; Efgeny Fominskiy; Stefano Franchini; Marzia Spessot; Carlo Martinenghi; Michele Carlucci; Luigi Beretta; Anna Maria Scandroglio; Massimo Clementi; Massimo Locatelli; Moreno Tresoldi; Paolo Scarpellini; Gianvito Martino; Emanuele Bosi; Lorenzo Dagna; Adriano Lazzarin; Giovanni Landoni; Alberto Zangrillo
Journal:  Clin Immunol       Date:  2020-06-12       Impact factor: 3.969

10.  Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19).

Authors:  Giuseppe Lippi; Brandon Michael Henry
Journal:  Respir Med       Date:  2020-03-24       Impact factor: 4.582

View more
  5 in total

1.  Phylogenetic analysis and comparative genomics of SARS-CoV-2 from survivor and non-survivor COVID-19 patients in Cordoba, Argentina.

Authors:  Nadia B Olivero; Ana S Gonzalez-Reiche; Viviana E Re; Gonzalo M Castro; María B Pisano; Paola Sicilia; María G Barbas; Zenab Khan; Adriana van de Guchte; Jayeeta Dutta; Paulo R Cortes; Mirelys Hernandez-Morfa; Victoria E Zappia; Lucia Ortiz; Ginger Geiger; Daniela Rajao; Daniel R Perez; Harm van Bakel; Jose Echenique
Journal:  BMC Genomics       Date:  2022-07-14       Impact factor: 4.547

2.  Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP).

Authors:  Daniele Zama; Francesco Baccelli; Antonella Colombini; Amalia Contino; Elisabetta Calore; Maria Grazia Petris; Linda Meneghello; Federico Mercolini; Andrea Lo Vecchio; Shana Montalto; Cristina Meazza; Angelica Barone; Francesca Compagno; Paola Muggeo; Elena Soncini; Letizia Brescia; Eugenia Giraldi; Nagua Giurici; Rosa Maria Mura; Monica Cellini; Katia Perruccio; Valeria Petroni; Milena La Spina; Ottavio Ziino; Roberta Burnelli; Raffaella De Santis; Maurizio Mascarin; Valentina Barretta; Gloria Tridello; Simone Cesaro
Journal:  Ann Hematol       Date:  2022-06-20       Impact factor: 4.030

3.  COVID-19 and Influenza Vaccination Campaign in a Research and University Hospital in Milan, Italy.

Authors:  Maurizio Lecce; Giacomo Biganzoli; Luca Agnello; Ignazio Belisario; Giovanni Cicconi; Marilena D'Amico; Francesca De Giorgi; Angelo Ferilli; Gaia Ferraguzzi; Fabio Guzzardi; Danilo Lanzillotti; Roberta Lattanzio; Chiara Marrocu; Maria Emanuela Noto; Sara Piccinelli; Noemi Sabatelli; Sheila Santisteban; Sudwaric Sharma; Livia Tognaccini; Silvana Castaldi
Journal:  Int J Environ Res Public Health       Date:  2022-05-26       Impact factor: 4.614

4.  COVID-19 Impact on Public Dental Healthcare in Bosnia and Herzegovina: Current Situation and Ongoing Perspectives.

Authors:  Elmedin Bajrić; Amila Zukanović; Nina Marković; Amra Arslanagić; Amina Huseinbegović; Mediha Selimović-Dragaš; Sedin Kobašlija; Aleksandra Popovac; Dejan Marković
Journal:  Int J Environ Res Public Health       Date:  2022-09-19       Impact factor: 4.614

5.  Impact of the COVID-19 Pandemic on the Therapeutic Continuity among Outpatients with Chronic Cardiovascular Therapies.

Authors:  Manuela Casula; Federica Galimberti; Marica Iommi; Elena Olmastroni; Simona Rosa; Mattia Altini; Alberico L Catapano; Elena Tragni; Elisabetta Poluzzi
Journal:  Int J Environ Res Public Health       Date:  2022-09-24       Impact factor: 4.614

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.